Collagen biology making inroads into prognosis and treatment of cancer progression and metastasis
暂无分享,去创建一个
Sandra Casimiro | S. Casimiro | L. Costa | Ana C. Martins Cavaco | Sara Dâmaso | Luís Costa | Ana C Martins Cavaco | S. Dâmaso
[1] A. Harris,et al. Collagen XV: Exploring Its Structure and Role within the Tumor Microenvironment , 2013, Molecular Cancer Research.
[2] M. Karsdal,et al. High turnover of extracellular matrix reflected by specific protein fragments measured in serum is associated with poor outcomes in two metastatic breast cancer cohorts , 2018, International journal of cancer.
[3] Daniela Pankova,et al. RASSF1A controls tissue stiffness and cancer stem‐like cells in lung adenocarcinoma , 2019, The EMBO journal.
[4] Carlos Cuevas,et al. Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma. , 2012, Cancer cell.
[5] M. Franchi,et al. Collagen Fiber Array of Peritumoral Stroma Influences Epithelial-to-Mesenchymal Transition and Invasive Potential of Mammary Cancer Cells , 2019, Journal of clinical medicine.
[6] K. Hiroshima,et al. Overexpression of Collagen XVIII Is Associated with Poor Outcome and Elevated Levels of Circulating Serum Endostatin in Non–Small Cell Lung Cancer , 2004, Clinical Cancer Research.
[7] Yan Li,et al. Collagen as a double-edged sword in tumor progression , 2013, Tumor Biology.
[8] W. You,et al. Tumorigenesis and Neoplastic Progression Collagen VI Ablation Retards Brain Tumor Progression Due to Deficits in Assembly of the Vascular Basal Lamina , 2012 .
[9] Clair Baldock,et al. Collagens at a glance , 2007, Journal of Cell Science.
[10] Somnath Mukherjee,et al. The prognostic role of desmoplastic stroma in pancreatic ductal adenocarcinoma , 2015, Oncotarget.
[11] S. Carr,et al. Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters , 2014, eLife.
[12] Haiyang Xie,et al. COL6A1 promotes metastasis and predicts poor prognosis in patients with pancreatic cancer , 2019, International journal of oncology.
[13] R. Gan,et al. NC1 domain of human type VIII collagen (alpha 1) inhibits bovine aortic endothelial cell proliferation and causes cell apoptosis. , 2001, Biochemical and biophysical research communications.
[14] Valerie Speirs,et al. MiR-26b is down-regulated in carcinoma-associated fibroblasts from ER-positive breast cancers leading to enhanced cell migration and invasion , 2013, The Journal of pathology.
[15] A. Popel,et al. Identification of novel short peptides derived from the α4, α5, and α6 fibrils of type IV collagen with anti-angiogenic properties , 2007 .
[16] J. Pichler,et al. Inhibition of TGF-β2 with AP 12009 in Recurrent Malignant Gliomas: From Preclinical to Phase I/II Studies , 2007 .
[17] M. Tan,et al. Collagen Induces a More Proliferative, Migratory and Chemoresistant Phenotype in Head and Neck Cancer via DDR1 , 2019, Cancers.
[18] Y. Bao,et al. Tumor‐associated macrophages promote bladder tumor growth through PI3K/AKT signal induced by collagen , 2019, Cancer science.
[19] Brian W Pogue,et al. Elastography Can Map the Local Inverse Relationship between Shear Modulus and Drug Delivery within the Pancreatic Ductal Adenocarcinoma Microenvironment , 2018, Clinical Cancer Research.
[20] Thomas Boehm,et al. Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance , 1997, Nature.
[21] J. Galván,et al. COL11A1/(pro)collagen 11A1 expression is a remarkable biomarker of human invasive carcinoma-associated stromal cells and carcinoma progression , 2015, Tumor Biology.
[22] P. Carmeliet,et al. Phenotype molding of stromal cells in the lung tumor microenvironment , 2018, Nature Medicine.
[23] E. Motrescu,et al. Matrix metalloproteinase-11/stromelysin-3 exhibits collagenolytic function against collagen VI under normal and malignant conditions , 2008, Oncogene.
[24] Kevin W Eliceiri,et al. Contact guidance mediated three-dimensional cell migration is regulated by Rho/ROCK-dependent matrix reorganization. , 2008, Biophysical journal.
[25] S. Ricard-Blum,et al. Tetrastatin, the NC1 Domain of the α4(IV) Collagen Chain: A Novel Potent Anti-Tumor Matrikine , 2012, PloS one.
[26] R. Faccio,et al. The type II collagen N-propeptide, PIIBNP, inhibits cell survival and bone resorption of osteoclasts via integrin-mediated signaling. , 2011, Bone.
[27] Magnus B Lilledahl,et al. Alterations in collagen fibre patterns in breast cancer. A premise for tumour invasiveness? , 2015, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[28] V. Chinchilli,et al. Baseline serum NTx levels are prognostic in metastatic breast cancer patients with bone-only metastasis. , 2004, Annals of oncology : official journal of the European Society for Medical Oncology.
[29] X. Bian,et al. Vastatin, an Endogenous Antiangiogenesis Polypeptide That Is Lost in Hepatocellular Carcinoma, Effectively Inhibits Tumor Metastasis. , 2016, Molecular therapy : the journal of the American Society of Gene Therapy.
[30] J. Quigley,et al. Growth factor-induced angiogenesis in vivo requires specific cleavage of fibrillar type I collagen. , 2001, Blood.
[31] A. Feuchtinger,et al. Collagen type V promotes the malignant phenotype of pancreatic ductal adenocarcinoma. , 2015, Cancer letters.
[32] P. Scardino,et al. Reactive stroma as a predictor of biochemical-free recurrence in prostate cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[33] J. McGrath,et al. Suppression of TGFβ and Angiogenesis by Type VII Collagen in Cutaneous SCC. , 2016, Journal of the National Cancer Institute.
[34] Gary R. Grotendorst,et al. Increased content of Type V Collagen in desmoplasia of human breast carcinoma. , 1982, The American journal of pathology.
[35] Yuan Zhao,et al. A Potential Role of Collagens Expression in Distinguishing Between Premalignant and Malignant Lesions in Stomach , 2009, Anatomical record.
[36] J. Fox,et al. Host response to human breast Invasive Ductal Carcinoma (IDC) as observed by changes in the stromal proteome. , 2014, Journal of proteome research.
[37] Z. Gokaslan,et al. The effect of type III collagen on migration and invasion of human glioblastoma cell lines in vitro. , 1996, Cancer letters.
[38] Steven A. Carr,et al. The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices , 2011, Molecular & Cellular Proteomics.
[39] Y. Imamura,et al. Bone morphogenetic protein-1 processes the NH2-terminal propeptide, and a furin-like proprotein convertase processes the COOH-terminal propeptide of pro-alpha1(V) collagen. , 1998, The Journal of biological chemistry.
[40] P. Zhao,et al. All‐trans retinoic acid protects hepatocellular carcinoma cells against serum‐starvation‐induced cell death by upregulating collagen 8A2 , 2013, The FEBS journal.
[41] S. Keleş,et al. The bone morphogenetic protein 1/Tolloid-like metalloproteinases. , 2007, Matrix biology : journal of the International Society for Matrix Biology.
[42] B. Zetter,et al. A role for collagen XXIII in cancer cell adhesion, anchorage-independence and metastasis , 2012, Oncogene.
[43] Bin Wang,et al. A collagen-binding EGFR single-chain Fv antibody fragment for the targeted cancer therapy. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[44] Huile Gao,et al. A dual strategy to improve the penetration and treatment of breast cancer by combining shrinking nanoparticles with collagen depletion by losartan. , 2016, Acta biomaterialia.
[45] Y. Gho,et al. Endostatin Blocks Vascular Endothelial Growth Factor-mediated Signaling via Direct Interaction with KDR/Flk-1* , 2002, The Journal of Biological Chemistry.
[46] Hong Yang,et al. Clinical significance and biological role of cancer‐derived Type I collagen in lung and esophageal cancers , 2019, Thoracic cancer.
[47] C. Zhu,et al. The Differential Effect of Endothelial Cell Factors on In Vitro Motility of Malignant and Non-malignant Cells , 2008, Annals of Biomedical Engineering.
[48] M. Najafi,et al. Extracellular matrix (ECM) stiffness and degradation as cancer drivers , 2018, Journal of cellular biochemistry.
[49] S. Sen,et al. Matrix Elasticity Directs Stem Cell Lineage Specification , 2006, Cell.
[50] Wei Yu,et al. Tumor-secreted PAI-1 promotes breast cancer metastasis via the induction of adipocyte-derived collagen remodeling , 2019, Cell Communication and Signaling.
[51] T. Yen,et al. Using a cell line breast cancer progression system to identify biomarker candidates. , 2014, Journal of proteomics.
[52] E. Keller,et al. Type I Collagen Receptor (α2β1) Signaling Promotes the Growth of Human Prostate Cancer Cells within the Bone , 2006 .
[53] R. Xu,et al. Roles of PLODs in Collagen Synthesis and Cancer Progression , 2018, Front. Cell Dev. Biol..
[54] M. Karsdal,et al. Clinical value of serum hyaluronan and propeptide of type III collagen in patients with pancreatic cancer , 2020, International journal of cancer.
[55] Y. Huang,et al. Collagen Type VI Alpha 3 Chain Promotes Epithelial-Mesenchymal Transition in Bladder Cancer Cells via Transforming Growth Factor β (TGF-β)/Smad Pathway , 2018, Medical science monitor : international medical journal of experimental and clinical research.
[56] M. Hollingsworth,et al. Tumor suppression by collagen XV is independent of the restin domain. , 2012, Matrix biology : journal of the International Society for Matrix Biology.
[57] P. Naredi,et al. Type IV collagen is a tumour stroma-derived biomarker for pancreas cancer , 2009, British Journal of Cancer.
[58] D. H. Madsen,et al. Internalization of Collagen: An Important Matrix Turnover Pathway in Cancer , 2017 .
[59] A. E. del Río Hernández,et al. Role of Extracellular Matrix in Development and Cancer Progression , 2018, International journal of molecular sciences.
[60] M. Dickinson,et al. Cancer-Associated Fibroblasts Induce a Collagen Cross-link Switch in Tumor Stroma , 2015, Molecular Cancer Research.
[61] Gary R. Grotendorst,et al. Desmoplastic breast carcinoma as a source of human myofibroblasts. , 1984, The American journal of pathology.
[62] Jian Li,et al. Small-molecule anticancer compounds selectively target the hemopexin domain of matrix metalloproteinase-9. , 2011, Cancer research.
[63] William Arbuthnot Sir Lane,et al. Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.
[64] Valerie M. Weaver,et al. The extracellular matrix at a glance , 2010, Journal of Cell Science.
[65] M. Schwartz,et al. Integrins in Mechanotransduction* , 2004, Journal of Biological Chemistry.
[66] Lin Cui,et al. &agr;-Smooth Muscle Actin Expressing Stroma Promotes an Aggressive Tumor Biology in Pancreatic Ductal Adenocarcinoma , 2010, Pancreas.
[67] B. R. Bass,et al. 3D collagen alignment limits protrusions to enhance breast cancer cell persistence. , 2014, Biophysical journal.
[68] H. Ueno,et al. Novel Internationally Verified Method Reports Desmoplastic Reaction as the Most Significant Prognostic Feature For Disease-specific Survival in Stage II Colorectal Cancer , 2019, The American journal of surgical pathology.
[69] D. Vigetti,et al. Collagen VI and Hyaluronan: The Common Role in Breast Cancer , 2014, BioMed research international.
[70] T. Luider,et al. Up-regulation of collagen proteins in colorectal liver metastasis compared with normal liver tissue , 2018, The Journal of Biological Chemistry.
[71] J. Segall,et al. Intravital imaging of cell movement in tumours , 2003, Nature Reviews Cancer.
[72] K. Bussard,et al. The Bone Extracellular Matrix as an Ideal Milieu for Cancer Cell Metastases , 2019, Cancers.
[73] S. Dangi‐Garimella,et al. Pancreatic Cancer Cells Respond to Type I Collagen by Inducing Snail Expression to Promote Membrane Type 1 Matrix Metalloproteinase-dependent Collagen Invasion* , 2011, The Journal of Biological Chemistry.
[74] Tao Yin,et al. Targeting of cancer-associated fibroblasts enhances the efficacy of cancer chemotherapy by regulating the tumor microenvironment , 2016, Molecular medicine reports.
[75] D. Richel,et al. Phase I/II Study of LDE225 in Combination with Gemcitabine and Nab-Paclitaxel in Patients with Metastatic Pancreatic Cancer , 2017, Cancers.
[76] F. Maquart,et al. Matrikines from basement membrane collagens: a new anti-cancer strategy. , 2014, Biochimica et biophysica acta.
[77] T. Downs,et al. Expression Microarray Meta-Analysis Identifies Genes Associated with Ras/MAPK and Related Pathways in Progression of Muscle-Invasive Bladder Transition Cell Carcinoma , 2013, PloS one.
[78] A. Bosserhoff,et al. BMP activated Smad signaling strongly promotes migration and invasion of hepatocellular carcinoma cells. , 2012, Experimental and molecular pathology.
[79] R. Kalluri,et al. Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by alpha v beta 3 and alpha 5 beta 1 integrins. , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[80] P. Kim,et al. Increased extracellular matrix density disrupts E-cadherin/β-catenin complex in gastric cancer cells. , 2018, Biomaterials science.
[81] G. Shapiro,et al. A phase I clinical trial of navitoclax, a targeted high-affinity Bcl-2 family inhibitor, in combination with gemcitabine in patients with solid tumors , 2014, Investigational New Drugs.
[82] K. Eliceiri,et al. Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells , 2017, Breast Cancer Research.
[83] R. Kalluri,et al. Canstatin, a Novel Matrix-derived Inhibitor of Angiogenesis and Tumor Growth* , 2000, The Journal of Biological Chemistry.
[84] J. Risteli,et al. Elevated serum levels of type I collagen degradation marker ICTP and tissue inhibitor of metalloproteinase (TIMP) 1 are associated with poor prognosis in lung cancer. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[85] Y. Furuya,et al. Prognostic Value of the Serum Levels of Bone Formation and Bone Resorption Markers in Prostate Cancer Patients with Bone Metastasis , 1998, European Urology.
[86] Wei Zhang,et al. Differentially expressed genes between primary cancer and paired lymph node metastases predict clinical outcome of node-positive breast cancer patients , 2007, Breast Cancer Research and Treatment.
[87] H M Berman,et al. Crystal and molecular structure of a collagen-like peptide at 1.9 A resolution. , 1994, Science.
[88] J. Risteli,et al. Aberrant type I and type III collagen gene expression in human breast cancer in vivo , 1998, The Journal of pathology.
[89] M. Okada,et al. A current perspective of canstatin, a fragment of type IV collagen alpha 2 chain. , 2019, Journal of pharmacological sciences.
[90] M. Karsdal,et al. Vastatin (the NC1 domain of human type VIII collagen a1 chain) is linked to stromal reactivity and elevated in serum from patients with colorectal cancer , 2019, Cancer biology & therapy.
[91] D. Sherwood,et al. SPARC Promotes Cell Invasion In Vivo by Decreasing Type IV Collagen Levels in the Basement Membrane , 2016, bioRxiv.
[92] M. Rubin,et al. Collagen XXIII Expression Is Associated with Prostate Cancer Recurrence and Distant Metastases , 2007, Clinical Cancer Research.
[93] Zhepeng Wang,et al. Type IIB Procollagen NH2-propeptide Induces Death of Tumor Cells via Interaction with Integrins αVβ3 and αVβ5* , 2010, The Journal of Biological Chemistry.
[94] K. Eliceiri,et al. Aligned collagen is a prognostic signature for survival in human breast carcinoma. , 2011, The American journal of pathology.
[95] Raghu Kalluri,et al. Human tumstatin and human endostatin exhibit distinct antiangiogenic activities mediated by αvβ3 and α5β1 integrins , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[96] A. Hoffman,et al. Carbamoylphosphonate matrix metalloproteinase inhibitors 6: cis-2-aminocyclohexylcarbamoylphosphonic acid, a novel orally active antimetastatic matrix metalloproteinase-2 selective inhibitor--synthesis and pharmacodynamic and pharmacokinetic analysis. , 2008, Journal of medicinal chemistry.
[97] M. Karsdal,et al. Excessive collagen turnover products are released during colorectal cancer progression and elevated in serum from metastatic colorectal cancer patients , 2016, Scientific Reports.
[98] D. Visigalli,et al. The carboxyl terminal trimer of procollagen I induces pro-metastatic changes and vascularization in breast cancer cells xenografts , 2009, BMC Cancer.
[99] A. Friedl,et al. Heterogeneity of Gene Expression in Stromal Fibroblasts of Human Breast Carcinomas and Normal Breast , 2009, Oncogene.
[100] N. Boyd,et al. Mammographic density and the risk and detection of breast cancer. , 2007, The New England journal of medicine.
[101] J. Myllyharju. Intracellular Post-Translational Modifications of Collagens , 2005 .
[102] J. R. de los Toyos,et al. Overexpression of COL11A1 by Cancer-Associated Fibroblasts: Clinical Relevance of a Stromal Marker in Pancreatic Cancer , 2013, PloS one.
[103] E. Lundberg,et al. Type IV collagen stimulates pancreatic cancer cell proliferation, migration, and inhibits apoptosis through an autocrine loop , 2013, BMC Cancer.
[104] D. Veitch,et al. Type VII Collagen Is Required for Ras-Driven Human Epidermal Tumorigenesis , 2005, Science.
[105] M. Rezaei,et al. Collateral Damage Intended—Cancer-Associated Fibroblasts and Vasculature Are Potential Targets in Cancer Therapy , 2017, International journal of molecular sciences.
[106] R. Fridman,et al. Extracellular proteases as targets for treatment of cancer metastases. , 2004, Chemical Society reviews.
[107] R. Sanz-Pamplona,et al. Prediction of pathological response to neoadjuvant treatment in rectal cancer with a two-protein immunohistochemical score derived from stromal gene-profiling , 2017, Annals of oncology : official journal of the European Society for Medical Oncology.
[108] Angel V Peterchev,et al. Relative abundance of Akkermansia spp. and other bacterial phylotypes correlates with anxiety- and depressive-like behavior following social defeat in mice , 2019, Scientific Reports.
[109] M. Tai,et al. Increased endostatin/collagen XVIII expression correlates with elevated VEGF level and poor prognosis in hepatocellular carcinoma , 2005, Modern Pathology.
[110] Guoxin Li,et al. High expression of COL10A1 is associated with poor prognosis in colorectal cancer , 2018, OncoTargets and therapy.
[111] J. Isaacs,et al. Targeting carcinoma-associated fibroblasts within the tumor stroma with a fibroblast activation protein-activated prodrug. , 2012, Journal of the National Cancer Institute.
[112] E. Petricoin,et al. Adipocyte-derived collagen VI affects early mammary tumor progression in vivo, demonstrating a critical interaction in the tumor/stroma microenvironment. , 2005, The Journal of clinical investigation.
[113] U. Goessler,et al. Keloids: current concepts of pathogenesis (review). , 2009, International journal of molecular medicine.
[114] Youping Deng,et al. Collagen type IV alpha 1 (COL4A1) and collagen type XIII alpha 1 (COL13A1) produced in cancer cells promote tumor budding at the invasion front in human urothelial carcinoma of the bladder , 2017, Oncotarget.
[115] D. V. Von Hoff,et al. Effect of Gemcitabine and nab-Paclitaxel With or Without Hydroxychloroquine on Patients With Advanced Pancreatic Cancer: A Phase 2 Randomized Clinical Trial. , 2019, JAMA oncology.
[116] E. Jaffee,et al. The prognostic value of stroma in pancreatic cancer in patients receiving adjuvant therapy. , 2015, HPB : the official journal of the International Hepato Pancreato Biliary Association.
[117] Z. Halpern,et al. Tumor macrophages are pivotal constructors of tumor collagenous matrix , 2016, The Journal of experimental medicine.
[118] M. Karsdal,et al. Clinical Relevance of Collagen Protein Degradation Markers C3M and C4M in the Serum of Breast Cancer Patients Treated with Neoadjuvant Therapy in the GeparQuinto Trial , 2019, Senologie - Zeitschrift für Mammadiagnostik und -therapie.
[119] M. Marinkovich,et al. Molecular organization of the basement membrane zone. , 2011, Clinics in dermatology.
[120] Changhong Miao,et al. COL11A1 is overexpressed in recurrent non-small cell lung cancer and promotes cell proliferation, migration, invasion and drug resistance. , 2016, Oncology reports.
[121] Jin-ping Zheng,et al. The inhibitory effects of arresten protein on tumor formation. , 2012, Chinese medical sciences journal = Chung-kuo i hsueh k'o hsueh tsa chih.
[122] Tianyuan Zhang,et al. Canstatin-N fragment inhibits in vitro endothelial cell proliferation and suppresses in vivo tumor growth. , 2003, Biochemical and biophysical research communications.
[123] Z. Werb,et al. Tumors as organs: complex tissues that interface with the entire organism. , 2010, Developmental cell.
[124] Piotr Zawierucha,et al. Extracellular Matrix Proteins Expression Profiling in Chemoresistant Variants of the A2780 Ovarian Cancer Cell Line , 2014, BioMed research international.
[125] G. Adler,et al. Down-regulation of E-cadherin gene expression by collagen type I and type III in pancreatic cancer cell lines. , 2001, Cancer research.
[126] D. Greenspan,et al. α3 Chains of type V collagen regulate breast tumour growth via glypican-1 , 2017, Nature Communications.
[127] T. Guise,et al. Cancer to bone: a fatal attraction , 2011, Nature Reviews Cancer.
[128] I. Talbot,et al. Histological categorisation of fibrotic cancer stroma in advanced rectal cancer , 2004, Gut.
[129] Y. Tabata,et al. Type I collagen can function as a reservoir of basic fibroblast growth factor. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[130] Y. Imamura,et al. Bone Morphogenetic Protein-1 Processes the NH2-terminal Propeptide, and a Furin-like Proprotein Convertase Processes the COOH-terminal Propeptide of pro-α1(V) Collagen* , 1998, The Journal of Biological Chemistry.
[131] C. Brakebusch,et al. Cancer-associated fibroblasts: how do they contribute to metastasis? , 2019, Clinical & Experimental Metastasis.
[132] G. Xiong,et al. Membrane associated collagen XIII promotes cancer metastasis and enhances anoikis resistance , 2018, Breast Cancer Research.
[133] Hao Li,et al. The role of collagen in cancer: from bench to bedside , 2019, Journal of Translational Medicine.
[134] S. George,et al. Matrix metalloproteinase control of capillary morphogenesis. , 2008, Critical reviews in eukaryotic gene expression.
[135] Lisa Paysan,et al. Discoidin domain receptor 1 controls linear invadosome formation via a Cdc42–Tuba pathway , 2014, The Journal of cell biology.
[136] M. Fukae,et al. Maturation of collagenous tissue. Temporal sequence of formation of peptidyl lysine-derived cross-linking aldehydes and cross-links in collagen. , 1980, The Journal of biological chemistry.
[137] J. A. Chapman,et al. Collagen fibril formation. , 1996, The Biochemical journal.
[138] G. Caracciolo,et al. Prognostic value of desmoplastic reaction and lymphocytic infiltration in the management of breast cancer. , 1997, Panminerva medica.
[139] Zhen-ning Wang,et al. Relationship between collagen IV expression and biological behavior of gastric cancer. , 2000, World journal of gastroenterology.
[140] M E Nimni,et al. Collagen: structure, function, and metabolism in normal and fibrotic tissues. , 1983, Seminars in arthritis and rheumatism.
[141] P. Duijf,et al. In epithelial cancers, aberrant COL17A1 promoter methylation predicts its misexpression and increased invasion , 2016, Clinical Epigenetics.
[142] Ben S. Wittner,et al. Single-Cell RNA Sequencing Identifies Extracellular Matrix Gene Expression by Pancreatic Circulating Tumor Cells , 2014, Cell reports.
[143] A. Kulkarni,et al. Characteristics Associated with Citation Rate of the Medical Literature , 2007, PloS one.
[144] P. Laporta,et al. Absolute spectroscopy near 7.8 μm with a comb-locked extended-cavity quantum-cascade-laser , 2017, Scientific Reports.
[145] V. Sukhatme,et al. Endostatin Causes G1 Arrest of Endothelial Cells through Inhibition of Cyclin D1* , 2002, The Journal of Biological Chemistry.
[146] R. Kalluri,et al. Identification of the Anti-angiogenic Site within Vascular Basement Membrane-derived Tumstatin* , 2001, The Journal of Biological Chemistry.
[147] E. Brogi,et al. Multi-organ Site Metastatic Reactivation Mediated by Non-canonical Discoidin Domain Receptor 1 Signaling , 2016, Cell.
[148] T. Pihlajaniemi,et al. Type XIII collagen expression is induced during malignant transformation in various epithelial and mesenchymal tumours , 2005, The Journal of pathology.
[149] T. Pihlajaniemi,et al. Recombinant Human Collagen XV Regulates Cell Adhesion and Migration* , 2009, The Journal of Biological Chemistry.
[150] Ronald T Raines,et al. Collagen structure and stability. , 2009, Annual review of biochemistry.
[151] Zhenliang Sun,et al. Matrix Metalloproteinase Cleavable Nanoparticles for Tumor Microenvironment and Tumor Cell Dual-Targeting Drug Delivery. , 2017, ACS applied materials & interfaces.
[152] I. Sagi,et al. Phagocyte—extracellular matrix crosstalk empowers tumor development and dissemination , 2018, The FEBS journal.
[153] A. Ochiai,et al. Prognostic Significance of Fibrotic Focus in Invasive Ductal Carcinoma of the Breast: A Prospective Observational Study , 2002, Modern Pathology.
[154] Jeffrey W. Clark,et al. Total Neoadjuvant Therapy With FOLFIRINOX in Combination With Losartan Followed by Chemoradiotherapy for Locally Advanced Pancreatic Cancer: A Phase 2 Clinical Trial. , 2019, JAMA oncology.
[155] Catherine C. Park,et al. Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration. , 2015, Integrative biology : quantitative biosciences from nano to macro.
[156] A. Dietz,et al. Therapeutic effects of deleting cancer-associated fibroblasts in cholangiocarcinoma. , 2013, Cancer research.
[157] Type I collagen fibrils: an inducer of invadosomes , 2015, Oncotarget.
[158] S. Grässel,et al. Induction of type XVI collagen expression facilitates proliferation of oral cancer cells. , 2011, Matrix biology : journal of the International Society for Matrix Biology.
[159] P. Scherer,et al. Adipocyte-derived endotrophin promotes malignant tumor progression. , 2012, The Journal of clinical investigation.
[160] Daniela Pankova,et al. RASSF1A controls tissue stiffness and cancer stem‐like cells in lung adenocarcinoma , 2019, The EMBO journal.
[161] R. Timpl,et al. Mapping of SPARC/BM-40/Osteonectin-binding Sites on Fibrillar Collagens* , 2008, Journal of Biological Chemistry.
[162] Y. DeClerck. Desmoplasia: a response or a niche? , 2012, Cancer discovery.
[163] Carlos Rubio,et al. COL11A1 in FAP polyps and in sporadic colorectal tumors , 2001, BMC Cancer.
[164] Caroline H. Diep,et al. Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer , 2015, Clinical Cancer Research.
[165] J. Norman,et al. The Initiator Methionine tRNA Drives Secretion of Type II Collagen from Stromal Fibroblasts to Promote Tumor Growth and Angiogenesis , 2016, Current Biology.
[166] S. Astigiano,et al. Procollagen I COOH-terminal fragment induces VEGF-A and CXCR4 expression in breast carcinoma cells. , 2008, Experimental cell research.
[167] T. Salo,et al. Alterations of Collagen XVII Expression During Transformation of Oral Epithelium to Dysplasia and Carcinoma , 2003, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[168] R. Jain,et al. Losartan inhibits collagen I synthesis and improves the distribution and efficacy of nanotherapeutics in tumors , 2011, Proceedings of the National Academy of Sciences.
[169] S. Thomas,et al. Tumor matrix protein collagen XIα1 in cancer. , 2015, Cancer letters.
[170] M. Ringuette,et al. Is SPARC an Evolutionarily Conserved Collagen Chaperone? , 2007, Journal of dental research.
[171] R. Gillies,et al. Collagen Production and Niche Engineering: A Novel Strategy for Cancer Cells to Survive Acidosis and Evolve , 2019, bioRxiv.
[172] B. Gumbiner,et al. Cell Adhesion: The Molecular Basis of Tissue Architecture and Morphogenesis , 1996, Cell.
[173] Emmanouil D Karagiannis,et al. Pentastatin-1, a collagen IV derived 20-mer peptide, suppresses tumor growth in a small cell lung cancer xenograft model , 2010, BMC Cancer.
[174] S. Leikin,et al. Procollagen Triple Helix Assembly: An Unconventional Chaperone-Assisted Folding Paradigm , 2007, PloS one.
[175] Michael D West,et al. COL10A1 expression is elevated in diverse solid tumor types and is associated with tumor vasculature. , 2012, Future oncology.
[176] Chau-Chyun Sheu,et al. Great potential of a panel of multiple hMTH1, SPD, ITGA11 and COL11A1 markers for diagnosis of patients with non-small cell lung cancer. , 2006, Oncology reports.
[177] Rakesh K Jain,et al. Molecular regulation of vessel maturation , 2003, Nature Medicine.
[178] J. Pollard,et al. Macrophages promote collagen fibrillogenesis around terminal end buds of the developing mammary gland , 2006, Developmental dynamics : an official publication of the American Association of Anatomists.
[179] L. Liotta,et al. Signal transduction for chemotaxis and haptotaxis by matrix molecules in tumor cells , 1990, The Journal of cell biology.
[180] S. Murphy,et al. The activated transforming growth factor‐beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer , 2012, International journal of cancer.
[181] J. Ramshaw,et al. Electrostatic interactions involving lysine make major contributions to collagen triple-helix stability. , 2005, Biochemistry.
[182] L. Camardella,et al. Trimer Carboxyl Propeptide of Collagen I Produced by Mature Osteoblasts Is Chemotactic for Endothelial Cells* , 2000, The Journal of Biological Chemistry.
[183] Marta Canuti,et al. Influenza and Other Respiratory Viruses Involved in Severe Acute Respiratory Disease in Northern Italy during the Pandemic and Postpandemic Period (2009–2011) , 2014, BioMed research international.
[184] R. Schmid,et al. Identification, culture, and characterization of pancreatic stellate cells in rats and humans. , 1998, Gastroenterology.
[185] H. Ploegh,et al. Secreted cathepsin L generates endostatin from collagen XVIII , 2000, The EMBO journal.
[186] B. Karlan,et al. A Collagen-Remodeling Gene Signature Regulated by TGF-β Signaling Is Associated with Metastasis and Poor Survival in Serous Ovarian Cancer , 2013, Clinical Cancer Research.
[187] D. Ryu,et al. Cancer-Associated Fibroblasts and Desmoplastic Reactions Related to Cancer Invasiveness in Patients With Colorectal Cancer , 2019, Annals of coloproctology.
[188] You-hong Cui,et al. Reorganized Collagen in the Tumor Microenvironment of Gastric Cancer and Its Association with Prognosis , 2017, Journal of Cancer.
[189] S. Casimiro,et al. Molecular Mechanisms of Bone Metastasis: Which Targets Came from the Bench to the Bedside? , 2016, International journal of molecular sciences.
[190] Ji-Hak Jeong,et al. Targeting Tumor Microenvironment by Small-Molecule Inhibitors , 2019, Translational oncology.
[191] C. Billottet,et al. Physiological type I collagen organization induces the formation of a novel class of linear invadosomes , 2012, Molecular biology of the cell.
[192] J. Wolfe. Breast patterns as an index of risk for developing breast cancer. , 1976, AJR. American journal of roentgenology.
[193] Z. Werb,et al. Regulation of matrix biology by matrix metalloproteinases. , 2004, Current opinion in cell biology.
[194] J. Watkinson,et al. Multi-cancer computational analysis reveals invasion-associated variant of desmoplastic reaction involving INHBA, THBS2 and COL11A1 , 2010, BMC Medical Genomics.
[195] K. Ng,et al. OT-101: An anti-TGF-beta-2 antisense- primed tumors to subsequent chemotherapies. , 2016 .
[196] B. le Bail,et al. Myofibroblasts are responsible for collagen synthesis in the stroma of human hepatocellular carcinoma: an in vivo and in vitro study. , 1999, Journal of hepatology.
[197] E. Keller,et al. Type I collagen receptor (alpha 2 beta 1) signaling promotes the growth of human prostate cancer cells within the bone. , 2006, Cancer research.
[198] L. Jia,et al. siRNA‐targeted COL8A1 inhibits proliferation, reduces invasion and enhances sensitivity to D‐limonence treatment in hepatocarcinoma cells , 2009, IUBMB life.
[199] A. Bosserhoff,et al. Inhibition of Collagen XVI Expression Reduces Glioma Cell Invasiveness , 2011, Cellular Physiology and Biochemistry.
[200] Olga Antipova,et al. Collagen fibril architecture, domain organization, and triple-helical conformation govern its proteolysis , 2008, Proceedings of the National Academy of Sciences.
[201] A. Suceveanu,et al. Introduction of cytogenetic tests in colorectal cancer screening. , 2009, Journal of gastrointestinal and liver diseases : JGLD.
[202] V. Sukhatme,et al. Antiangiogenic activity of restin, NC10 domain of human collagen XV: comparison to endostatin. , 1999, Biochemical and biophysical research communications.
[203] C. López-Otín,et al. Arresten, a Collagen-Derived Angiogenesis Inhibitor, Suppresses Invasion of Squamous Cell Carcinoma , 2012, PloS one.
[204] D. V. Von Hoff,et al. Parallel Accumulation of Tumor Hyaluronan, Collagen, and Other Drivers of Tumor Progression , 2018, Clinical Cancer Research.
[205] Eleftherios P. Diamandis,et al. Proteomic Signatures of the Desmoplastic Invasion Front Reveal Collagen Type XII as a Marker of Myofibroblastic Differentiation During Colorectal Cancer Metastasis , 2012, Oncotarget.
[206] Jieqing Zhu,et al. Prolyl-4-hydroxylase α subunit 2 promotes breast cancer progression and metastasis by regulating collagen deposition , 2014, BMC Cancer.
[207] D. E. Discher,et al. Matrix elasticity directs stem cell lineage — Soluble factors that limit osteogenesis , 2009 .
[208] A. Egloff,et al. Collagen type XI α1 facilitates head and neck squamous cell cancer growth and invasion , 2013, British Journal of Cancer.
[209] J. Erler,et al. Lysyl oxidase in cancer research. , 2014, Future oncology.
[210] H. Ueno,et al. Histologic Categorization of Fibrotic Cancer Stroma in the Primary Tumor Is an Independent Prognostic Index in Resectable Colorectal Liver Metastasis , 2014, The American journal of surgical pathology.
[211] N F Boyd,et al. Growth factors and stromal matrix proteins associated with mammographic densities. , 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[212] J. Hubbell,et al. Targeted antibody and cytokine cancer immunotherapies through collagen affinity , 2019, Science Translational Medicine.
[213] S. Lorkowski,et al. Production of Type VI Collagen by Human Macrophages: A New Dimension in Macrophage Functional Heterogeneity1 2 , 2008, The Journal of Immunology.
[214] Kevin W. Eliceiri,et al. Automated quantification of aligned collagen for human breast carcinoma prognosis , 2014, Journal of pathology informatics.
[215] A. Lindblom,et al. Colorectal carcinogenesis is associated with stromal expression of COL11A1 and COL5A2. , 2001, Carcinogenesis.
[216] Y. Nishiwaki,et al. Prognostic implications of fibrotic focus (scar) in small peripheral lung cancers , 1980, The American journal of surgical pathology.
[217] M. Dauchez,et al. Conformation-dependent binding of a Tetrastatin peptide to αvβ3 integrin decreases melanoma progression through FAK/PI3K/Akt pathway inhibition , 2018, Scientific Reports.
[218] I. Peretz,et al. Individual Differences in Rhythmic Cortical Entrainment Correlate with Predictive Behavior in Sensorimotor Synchronization , 2016, Scientific Reports.
[219] S. Ricard-Blum. The collagen family. , 2011, Cold Spring Harbor perspectives in biology.
[220] T. Andl,et al. Cancer-Associated Fibroblasts Build and Secure the Tumor Microenvironment , 2019, Front. Cell Dev. Biol..
[221] Kevin W Eliceiri,et al. A subset of myofibroblastic cancer-associated fibroblasts regulate collagen fiber elongation, which is prognostic in multiple cancers , 2015, Oncotarget.
[222] M. Karsdal,et al. Collagen fragments quantified in serum as measures of desmoplasia associate with survival outcome in patients with advanced pancreatic cancer , 2019, Scientific Reports.
[223] Marie C. M. Lin,et al. Enhanced expression of Vastatin inhibits angiogenesis and prolongs survival in murine orthotopic glioblastoma model , 2017, BMC Cancer.
[224] R. Uslu,et al. Cancer stem cell differentiation: TGFβ1 and versican may trigger molecules for the organization of tumor spheroids. , 2014, Oncology reports.
[225] I. Talbot,et al. Clinicopathological significance of the `keloid‐like' collagen and myxoid stroma in advanced rectal cancer , 2002, Histopathology.